NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

So the books on ESMO are closed? While that is a little disappointing, I never really could get myself to believe ESMO was our stage. SNO has always been on their radar and it makes the most sense once ASCO was off the table. November will be here in the blink of an eye and a publication could really come any day now. That pathway remains on track until after SNO from my perspective.

The question I would like answered is where are we from a regulatory perspective? My expectation is that the ball has been moving forward on a parallel path. I don’t recall them ever foreshadowing any of the regulatory steps they have completed ahead of time,. I expect that progress is being made, but we are really kept in the dark there.

FOLD recently informed shareholders of a completed rolling application. I’m not certain that we would have known had they not reported it. I couldn’t find any FDA posting on it.